Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome


      To evaluate association with polycystic ovary syndrome (PCOS) of 295 variants in 39 genes central to metabolic insulin signaling and glycogen synthase kinase 3β (GSK-3β) regulation, followed by replication efforts.


      Case-control association study, with discovery and replication cohorts.


      Subjects were recruited from reproductive endocrinology clinics, and controls were recruited from communities surrounding the University of Alabama at Birmingham and Erasmus Medical Center, Rotterdam.


      A total of 273 cases with PCOS and 173 control subjects in the discovery cohort; and 526 cases and 3,585 control subjects in the replication cohort. All subjects were caucasian.


      Phenotypic and genotypic assessment.

      Main Outcome Measure(s)

      Detection of 295 single-nucleotide polymorphisms (SNPs), PCOS status.


      Several SNPs were associated with PCOS in the discovery cohort. Four insulin receptor (INSR) SNPs and three insulin receptor substrate 2 (IRS2) SNPs associated with PCOS were genotyped in the replication cohort. One INSR SNP (rs2252673) replicated association with PCOS. The minor allele conferred increased odds of PCOS in both cohorts, independent of body mass index.


      A pathway-based tagging SNP approach allowed us to identify novel INSR SNPs associated with PCOS, one of which confirmed association in a large replication cohort.

      Key Words

      To read this article in full you will need to make a payment


      Subscribe to Fertility and Sterility
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • DeUgarte C.M.
        • Bartolucci A.A.
        • Azziz R.
        Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment.
        Fertil Steril. 2005; 83: 1454-1460
        • Palomba S.
        • Falbo A.
        • Zullo F.
        • Orio F.
        Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.
        Endocr Rev. 2009; 30: 1-50
        • Goodarzi M.O.
        Looking for polycystic ovary syndrome genes: rational and best strategy.
        Semin Reprod Med. 2008; 26: 5-13
        • Legro R.S.
        • Bentley-Lewis R.
        • Driscoll D.
        • Wang S.C.
        • Dunaif A.
        Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.
        J Clin Endocrinol Metab. 2002; 87: 2128-2133
        • Ioannidis A.
        • Ikonomi E.
        • Dimou N.L.
        • Douma L.
        • Bagos P.G.
        Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: A mendelian randomization meta-analysis.
        Mol Genet Metab. 2009;
        • Lizcano J.M.
        • Alessi D.R.
        The insulin signalling pathway.
        Curr Biol. 2002; 12: R236-R238
        • Baumann C.A.
        • Saltiel A.R.
        Spatial compartmentalization of signal transduction in insulin action.
        Bioessays. 2001; 23: 215-222
        • Simoni M.
        • Tempfer C.B.
        • Destenaves B.
        • Fauser B.C.
        Functional genetic polymorphisms and female reproductive disorders: part I: polycystic ovary syndrome and ovarian response.
        Hum Reprod Update. 2008; 14: 459-484
        • Doble B.W.
        • Woodgett J.R.
        GSK-3: tricks of the trade for a multi-tasking kinase.
        J Cell Sci. 2003; 116: 1175-1186
        • Chang W.
        • Goodarzi M.O.
        • Williams H.
        • Magoffin D.A.
        • Pall M.
        • Azziz R.
        Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3.
        Fertil Steril. 2008; 90: 2291-2297
        • Goodarzi M.O.
        • Antoine H.J.
        • Pall M.
        • Cui J.
        • Guo X.
        • Azziz R.
        Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome.
        Fertil Steril. 2007; 87: 1473-1476
        • Goodarzi M.O.
        • Jones M.R.
        • Chen Y.D.
        • Azziz R.
        First evidence of genetic association between AKT2 and polycystic ovary syndrome.
        Diabetes Care. 2008; 31: 2284-2287
        • Zawadzki J.
        • Dunaif A.
        Diagnostic criteria for polycystic ovary syndrome: toward a rational approach.
        in: Dunaif A. Givens J.R. Haseltine F.P. Merriam G.R. Polycystic ovary syndrome. Blackwell Scientific, Boston1992: 377-384
        • Azziz R.
        • Woods K.S.
        • Reyna R.
        • Key T.J.
        • Knochenhauer E.S.
        • Yildiz B.O.
        The prevalence and features of the polycystic ovary syndrome in an unselected population.
        J Clin Endocrinol Metab. 2004; 89: 2745-2749
        • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
        Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.
        Fertil Steril. 2004; 81: 19-25
        • Hofman A.
        • Breteler M.M.
        • van Duijn C.M.
        • Krestin G.P.
        • Pols H.A.
        • Stricker B.H.
        • et al.
        The Rotterdam Study: objectives and design update.
        Eur J Epidemiol. 2007; 22: 819-829
        • Gunderson K.L.
        • Steemers F.J.
        • Ren H.
        • Ng P.
        • Zhou L.
        • Tsan C.
        • et al.
        Whole-genome genotyping.
        Methods Enzymol. 2006; 410: 359-376
        • Kosoy R.
        • Nassir R.
        • Tian C.
        • White P.A.
        • Butler L.M.
        • Silva G.
        • et al.
        Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America.
        Hum Mutat. 2009; 30: 69-78
        • Purcell S.
        • Cherny S.S.
        • Sham P.C.
        Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.
        Bioinformatics. 2003; 19: 149-150
        • Jin L.
        • Zhu X.M.
        • Luo Q.
        • Qian Y.
        • Jin F.
        • Huang H.F.
        A novel SNP at exon 17 of INSR is associated with decreased insulin sensitivity in Chinese women with PCOS.
        Mol Hum Reprod. 2006; 12: 151-155
        • Lee E.J.
        • Oh B.
        • Lee J.Y.
        • Kimm K.
        • Lee S.H.
        • Baek K.H.
        A novel single nucleotide polymorphism of INSR gene for polycystic ovary syndrome.
        Fertil Steril. 2008; 89: 1213-1220
        • Stewart D.R.
        • Dombroski B.A.
        • Urbanek M.
        • Ankener W.
        • Ewens K.G.
        • Wood J.R.
        • et al.
        Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity.
        J Clin Endocrinol Metab. 2006; 91: 4112-4117
        • Azziz R.
        • Dumesic D.A.
        • Goodarzi M.O.
        Polycystic ovary syndrome: an ancient disorder?.
        Fertil Steril. 2010;
        • International HapMap Consortium
        The International HapMap Project.
        Nature. 2003; 426: 789-796
        • Belfiore A.
        • Frasca F.
        • Pandini G.
        • Sciacca L.
        • Vigneri R.
        Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.
        Endocr Rev. 2009; 30: 586-623
        • Goodarzi M.O.
        • Jones M.R.
        • Antoine H.J.
        • Pall M.
        • Chen Y.D.
        • Azziz R.
        Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.
        J Clin Endocrinol Metab. 2008; 93: 300-303
        • Jones M.R.
        • Mathur R.
        • Cui J.
        • Guo X.
        • Azziz R.
        • Goodarzi M.O.
        Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene.
        J Clin Endocrinol Metab. 2009; 94: 5034-5038
        • Gaasenbeek M.
        • Powell B.L.
        • Sovio U.
        • Haddad L.
        • Gharani N.
        • Bennett A.
        • et al.
        Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone.
        J Clin Endocrinol Metab. 2004; 89: 2408-2413
        • Powell B.L.
        • Haddad L.
        • Bennett A.
        • Gharani N.
        • Sovio U.
        • Groves C.J.
        • et al.
        Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits.
        J Clin Endocrinol Metab. 2005; 90: 2988-2993
        • Ewens K.G.
        • Stewart D.R.
        • Ankener W.
        • Urbanek M.
        • McAllister J.M.
        • Chen C.
        • et al.
        Family-based analysis of candidate genes for polycystic ovary syndrome.
        J Clin Endocrinol Metab. 2010; 95: 2306-2315
        • Kraft P.
        Curses—winner’s and otherwise—in genetic epidemiology.
        Epidemiology. 2008; 19: 649-651